การเปรียบเทียบผลของการลดระดับไขมันและน้ำตาลในเลือด ระหว่างยา Pioglitazone และ Rosiglitazone ในผู้ป่วยเบาหวานชนิดที่ 2 ที่มีระดับไขมันในเลือดสูง

บทคัดย่อ

The Thiazolidinediones are the most useful antidiabetic agents and differ from older classes. They have been considerable interested in both ability to lower blood glucose and effects on lipid profile. The retrospective descriptive study for seventyeight type 2 diabetic dyslipidemia patients whom enrolled in DM clinic of Somdejphraphultalertla Hospital during July 1, 2006 to Febuary 29, 2008 and divided equally in 2 groups of Pioglitazone and Rosiglitazone. After comparison of the glycemic lowing effects and effects on lipid compenent. It was founded that Pioglitazone group had more beneficial effects on fasting blood glucose level than Rosiglitazone group. Both groups had no significant effect in statistics for lipid profile.